Premium
A novel derivative of decursin, CSL‐32, blocks migration and production of inflammatory mediators and modulates PI3K and NF‐κB activities in HT1080 cells
Author(s) -
Lee SeungHee,
Lee Jee Hyun,
Kim EunJu,
Kim WonJung,
Suk Kyoungho,
Kim JooHwan,
Song Gyu Yong,
Lee WonHa
Publication year - 2012
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1042/cbi20110257
Subject(s) - ht1080 , nf κb , derivative (finance) , pi3k/akt/mtor pathway , chemistry , microbiology and biotechnology , biology , biochemistry , signal transduction , cell , business , finance
Decursin and related coumarin compounds in herbal extracts have a number of biological activities against inflammation, angiogenesis and cancer. We have analysed a derivative of decursin (CSL‐32) for activity against inflammatory activation of cancer cells, such as migration, invasion and expression of pro‐inflammatory mediators. The human fibrosarcoma cell line, HT1080, was treated with TNFα (tumour necrosis factor α) in the presence or absence of CSL‐32. The cellular responses and modification of signalling adapters were analysed with respect to the production of pro‐inflammatory mediators, as also migration, adhesion and invasion. Treatment of HT1080 cells with CSL‐32 inhibited their proliferation, without affecting cell viability, and TNFα‐induced expression of pro‐inflammatory mediators, such as MMP‐9 (matrix metalloproteinase‐9) and IL‐8 (interleukin‐8). CSL‐32 also suppressed phosphorylation and degradation of IκB (inhibitory κB), phosphorylation of p65 subunit of NF‐κB (nuclear factor‐κB) and nuclear translocation of NF‐κB, which are required for the expression of pro‐inflammatory mediators. In addition, CSL‐32 inhibited invasion and migration of HT1080 cells, as also cellular adhesion to fibronectin, an ECM (extracellular matrix) protein. CSL‐32 treatment resulted in a dose‐dependent inhibition of PI3K (phosphoinositide 3‐kinase) activity, required for the cellular migration. The analyses show that CSL‐32 inhibits processes associated with inflammation, such as the production of pro‐inflammatory mediators, as well as adhesion, migration and invasion in HT1080 cells.